IBD for Clinicians: what the book covers and who it is for

Caring for someone with inflammatory bowel disease is no longer only about controlling diarrhoea and pain. The aim of modern treatment is sustained, steroid-free remission, prevention of bowel damage, and protection of nutrition, function and quality of life. Reaching that aim depends on getting many decisions right: the diagnosis, the choice of drug, the timing of escalation, and the monitoring that follows.

IBD for Clinicians was written to bring those decisions together in one place, updated against the 2025 British Society of Gastroenterology guideline on IBD in adults.

What is inside

• Diagnosis and classification, with a defensible strategy for biopsies and imaging.
• Disease activity scores worked through, including Truelove and Witts, Mayo, the Harvey-Bradshaw Index, CDAI, SES-CD, Rutgeerts and PUCAI.
• Treatment strategy for ulcerative colitis and Crohn’s disease.
• Thiopurines and methotrexate, including TPMT and NUDT15 testing and metabolite interpretation.
• Biologics and small molecules with current UK dosing and NICE and MHRA positions, plus therapeutic drug monitoring.
• Emergencies, including acute severe colitis.
• Perianal disease, surgery and pouchitis.
• Pregnancy, vaccination and infection prevention.
• Extraintestinal manifestations, nutrition and iron.
• Treat-to-target monitoring and colorectal cancer surveillance.

Who it is for

The book is a working companion for gastroenterology trainees and consultants, IBD specialist nurses, pharmacists and general physicians who see patients with IBD on the ward or in clinic. It is also written with exams in mind: the scores and treatment pathways are the ones candidates are expected to know for specialty examinations.

It is not a replacement for local protocols or for the full guideline. It is designed to sit beside them, so that the essentials of current UK practice are quick to find when a decision has to be made.

IBD for Clinicians is available as a Kindle eBook and a paperback on Amazon.